Skip to main navigation Skip to main content

CMH : Clinical and Molecular Hepatology

OPEN ACCESS
ABOUT
BROWSE ARTICLES
FOR CONTRIBUTORS

Page Path

3
results for

"Sung-Gyu Lee"

Article category

Keywords

Publication year

"Sung-Gyu Lee"

Original Article

Liver Transplantation

Immunosuppression status of liver transplant recipients with hepatitis C affects biopsy-proven acute rejection
Jong Man Kim, Kwang-Woong Lee, Gi-Won Song, Bo-Hyun Jung, Hae Won Lee, Nam-Joon Yi, ChoonHyuck David Kwon, Shin Hwang, Kyung-Suk Suh, Jae-Won Joh, Suk-Koo Lee, Sung-Gyu Lee
Clin Mol Hepatol 2016;22(3):366-371.
Published online September 25, 2016
DOI: https://doi.org/10.3350/cmh.2016.0022
Background/Aims
The relationship between patient survival and biopsy-proven acute rejection (BPAR) in liver transplant recipients with hepatitis C remains unclear. The aims of this study were to compare the characteristics of patients with and without BPAR and to identify risk factors for BPAR.
Methods
We retrospectively reviewed the records of 169 HCV-RNA-positive patients who underwent LT at three centers.
Results
BPAR occurred in 39 (23.1%) of the HCV-RNA-positive recipients after LT. The 1-, 3-, and 5-year survival rates were 92.1%, 90.3%, and 88.5%, respectively, in patients without BPAR, and 75.7%, 63.4%, and 58.9% in patients with BPAR (P<0.001). Multivariate analyses showed that BPAR was associated with the non-use of basiliximab and tacrolimus and the use of cyclosporin in LT recipients with HCV RNA-positive.
Conclusions
The results of the present study suggest that the immunosuppression status of HCV-RNA-positive LT recipients should be carefully determined in order to prevent BPAR and to improve patient survival.

Citations

Citations to this article as recorded by  Crossref logo
  • Early use of everolimus improved renal function after adult deceased donor liver transplantation
    Seohee Lee, Jong Man Kim, Sangjin Kim, Jinsoo Rhu, Gyu-Seong Choi, Jae-Won Joh
    Korean Journal of Transplantation.2021; 35(1): 8.     CrossRef
  • 13,080 View
  • 148 Download
  • Crossref

Liver Imaging

Liver fibrosis, cirrhosis, and portal hypertension

Portal flow steal after liver transplantation
Bohyun Kim, Kyoung Won Kim, Gi-Won Song, Sung-Gyu Lee
Clin Mol Hepatol 2015;21(3):314-317.
Published online September 30, 2015
DOI: https://doi.org/10.3350/cmh.2015.21.3.314

Portal flow steal occasionally persists even after the liver transplantation, which may reduce the portal flow and thus threaten the patients' outcome. Therefore, pre- and peri-operative detection of portal steal phenomenon requiring radiological or surgical interruption is essential for the liver transplantation candidates as well as for the recipients.

Citations

Citations to this article as recorded by  Crossref logo
  • Late Onset Hepatic Encephalopathy after Living Donor Liver Transplant: Successful Reversal by Plug Embolization of Shunt—A Report of Two Cases
    Shahnawaz Bashir, Dibyalochan Praharaj, Adnan Khan, Subhash Gupta, Pragati Gakher
    Journal of Clinical Interventional Radiology ISVIR.2025;[Epub]     CrossRef
  • Portal Steal During Liver Transplantation in a 31-Year-Old: When Absent Varices Signal Extensive Splenorenal Shunting
    Noor Abu Zar, Chia Chey
    Cureus.2025;[Epub]     CrossRef
  • Clinical Impact of Spontaneous Portosystemic Shunts in Liver Transplantation: A Comprehensive Assessment Through Total Shunt Area Measurement
    Leonardo Centonze, Giovanna Gorga, Riccardo De Carlis, Davide Bernasconi, Andrea Lauterio, Luca Carbonaro, Ivan Vella, Cristiano Sgrazzutti, Niccolò Incarbone, Francesco Rizzetto, Maria Grazia Valsecchi, Angelo Vanzulli, Luciano De Carlis
    Transplantation.2023; 107(4): 913.     CrossRef
  • Short-Term Results of Plug-Assisted Retrograde Transvenous Obliteration for Portal Steal from Complicated Portosystemic Shunts in Living-Donor Liver Transplantation
    Gun Ha Kim, Dong Il Gwon, Gi-Young Ko, Hee Ho Chu, Deok-Bog Moon, Dong-Hwan Jung, Sung-Gyu Lee
    Journal of Vascular and Interventional Radiology.2023; 34(4): 645.     CrossRef
  • Imaging and Intervention in the Management of Vascular Complications Following Liver Transplantation
    Vijay Kubihal, Shridhar Sasturkar, Amar Mukund
    Journal of Clinical and Experimental Hepatology.2023; 13(5): 854.     CrossRef
  • Role of portocaval shunts in development of complications after liver transplantation
    D. L. Tsoy, M. I. Prudkov, O. G. Orlov, E. N. Bessonova, I. G. Leshchenko, L. V. Kardopoltsev, A. N. Ageev, S. I. Solodushkin
    Transplantologiya. The Russian Journal of Transplantation.2022; 14(2): 159.     CrossRef
  • Understanding Local Hemodynamic Changes After Liver Transplant: Different Entities or Simply Different Sides to the Same Coin?
    Francisco Calderon Novoa, Juan Mattera, Martín de Santibañes, Victoria Ardiles, Adrian Gadano, Daniel E D’Agostino, Eugenia Fratantoni, Eduardo De Santibañes, Juan Pekolj
    Transplantation Direct.2022; 8(9): e1369.     CrossRef
  • Life-Threatening Portal Flow Steal Reappearing Under Increased Intrahepatic Vascular Resistance After Living Donor Liver Transplantation
    Jae-Hyun Kwon, Young-In Yoon, Deok-Bog Moon, Gil-Chun Park, Gi-Won Song, Dong-Hwan Jung, Kyu-Bo Sung, Gi-Young Ko, Dong-Il Gwon, Yong-Kyu Jung, I-Ji Jeong, Jin-Uk Choi, Min-Jae Kim, Sang-Hoon Kim, Sung-Gyu Lee
    Transplantation Proceedings.2021; 53(1): 166.     CrossRef
  • Endovascular management of portal steal syndrome due to portosystemic shunts after living donor liver transplantation
    Surabhi Jajodia, Anubhav H Khandelwal, Rohit Khandelwal, Abhay K Kapoor, Sanjay S Baijal
    JGH Open.2021; 5(5): 599.     CrossRef
  • Post-transplant inflow modulation for early allograft dysfunction after living donor liver transplantation
    Mohamed Elshawy, Takeo Toshima, Yoshiki Asayama, Yuichiro Kubo, Shinichiro Ikeda, Toru Ikegami, Shingo Arakaki, Tomoharu Yoshizumi, Masaki Mori
    Surgical Case Reports.2020;[Epub]     CrossRef
  • N-butyl-2 cyanoacrylate (NBCA) embolus in the graft portal vein after portosystemic collateral embolization in liver transplantation recipient: what is the clinical significance?
    Hye Young Jang, Kyoung Won Kim, Jae Hyun Kwon, Heon-Ju Kwon, Bohyun Kim, Nieun Seo, Jeongjin Lee, Gi-Won Song, Sung-Gyu Lee
    Acta Radiologica.2017; 58(11): 1326.     CrossRef
  • 10,228 View
  • 104 Download
  • 8 Web of Science
  • Crossref
Case Report

Liver Transplantation

Liver transplantation for acute-on-chronic liver failure from erythropoietic protoporphyria
Pyoung-Jae Park, Shin Hwang, Young-Il Choi, Young-Dong Yu, Gil-Chun Park, Sung-Won Jung, Sam-Youl Yoon, Gi-Won Song, Tae-Yong Ha, Sung-Gyu Lee
Korean J Hepatol 2012;18(4):411-415.
Published online December 21, 2012
DOI: https://doi.org/10.3350/cmh.2012.18.4.411

Erythropoietic protoporphyria (EPP) is an inherited disorder of the heme metabolic pathway that is characterized by accumulation of protoporphyrin in the blood, erythrocytes, and tissues, and cutaneous manifestations of photosensitivity, all resulting from abnormalities in ferrochelatase (FECH) activity due to mutations in the FECH gene. Protoporphyrin is excreted by the liver, and excess protoporphyrin leads to cholelithiasis with obstructive episodes and chronic liver disease, finally progressing to liver cirrhosis. Patients with end-stage EPP-associated liver disease require liver transplantation. We describe here a 31-year-old male patient with EPP who experienced acute-on-chronic liver failure and underwent deceased-donor liver transplantation. Surgical and postoperative care included specific shielding from exposure to ultraviolet radiation to prevent photosensitivity-associated adverse effects. The patient recovered uneventfully and was doing well 24 months after transplantation. Future prevention and treatment of liver disease are discussed in detail.

Citations

Citations to this article as recorded by  Crossref logo
  • Machine learning-based plasma metabolomics for improved cirrhosis risk stratification
    Jingru Song, Ziwei Gao, Liqun Lai, Jie Zhang, Binbin Liu, Yi Sang, Siqi Chen, Jiachen Qi, Yujun Zhang, Huang Kai, Wei Ye
    BMC Gastroenterology.2025;[Epub]     CrossRef
  • Treatment strategy for erythropoietic protoporphyria accompanied by severe abdominal pain and liver injury
    Xiaoxin Wu, Xiumei Zhou, Shuai Zhao, Keting He, Wenxin Zhoudi, Shangci Chen, Xiaowei Xu
    Portal Hypertension & Cirrhosis.2024; 3(1): 36.     CrossRef
  • Liver involvement in patients with erythropoietic protoporphyria: retrospective analysis of clinicopathological features of 5 cases
    Chang Zhao, Jie-Xia Guan, Da-Yang Hui, Na-Na Zhang, Li-Rong Lu, Lu-Ying Tang, Chun-Kui Shao, Jian-Ning Chen
    Annals of Diagnostic Pathology.2022; 56: 151859.     CrossRef
  • Reappraisal of liver transplantation for erythropoietic protoporphyria: A deadly combination of disease recurrence and biliary complication
    Yutaka Endo, Taizo Hibi, Masahiro Shinoda, Hideaki Obara, Minoru Kitago, Hiroshi Yagi, Yuta Abe, Yasushi Hasegawa, Kentaro Matsubara, Shutaro Hori, Masayuki Tanaka, Satomi Makiuchi, Yutaka Nakano, Osamu Itano, Tatsuo Kuroda, Yuko Kitagawa
    Pediatric Transplantation.2022;[Epub]     CrossRef
  • Surgical treatment for breast cancer in a patient with erythropoietic protoporphyria and photosensitivity: a case report
    Akiko Shimazaki, Takuma Hashimoto, Masaya Kai, Tetsuzo Nakayama, Mai Yamada, Karen Zaguirre, Kentaro Tokuda, Makoto Kubo, Ken Yamaura, Masafumi Nakamura
    Surgical Case Reports.2021;[Epub]     CrossRef
  • Perioperative management of a bleeding jejunal tumor in a patient with erythropoietic protoporphyria: A case report and literature review
    Yuki Takemoto, Shoichiro Mukai, Tetsuya Mochizuki, Masatoshi Kochi, Hiroyuki Egi, Hideki Ohdan
    International Journal of Surgery Case Reports.2019; 60: 191.     CrossRef
  • Current and innovative emerging therapies for porphyrias with hepatic involvement
    Antonio Fontanellas, Matías A. Ávila, Karl E. Anderson, Jean-Charles Deybach
    Journal of Hepatology.2019; 71(2): 422.     CrossRef
  • Liver metabolomics in a mouse model of erythropoietic protoporphyria
    Pengcheng Wang, Madhav Sachar, Grace L. Guo, Amina I. Shehu, Jie Lu, Xiao-bo Zhong, Xiaochao Ma
    Biochemical Pharmacology.2018; 154: 474.     CrossRef
  • Cimetidine/lactulose therapy ameliorates erythropoietic protoporphyria-related liver injury
    Naoyuki Fujimori, Michiharu Komatsu, Naoki Tanaka, Mai Iwaya, Hajime Nakano, Ayumi Sugiura, Tomoo Yamazaki, Soichiro Shibata, Yugo Iwaya, Takashi Muraki, Yuki Ichikawa, Takefumi Kimura, Satoru Joshita, Takeji Umemura, Akihiro Matsumoto, Eiji Tanaka
    Clinical Journal of Gastroenterology.2017; 10(5): 452.     CrossRef
  • Les porphyries héréditaires : anomalies du métabolisme de l’hème
    K. Peoc’h, C. Martin-Schmitt, N. Talbi, J.-C. Deybach, L. Gouya, H. Puy
    La Revue de Médecine Interne.2016; 37(3): 173.     CrossRef
  • Porphyrias: A 2015 update
    Zoubida Karim, Said Lyoumi, Gael Nicolas, Jean-Charles Deybach, Laurent Gouya, Hervé Puy
    Clinics and Research in Hepatology and Gastroenterology.2015; 39(4): 412.     CrossRef
  • 11,370 View
  • 90 Download
  • Crossref